We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+7.57%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$20.9B
AUM Growth
+$1.18B
Cap. Flow
-$95.1M
Cap. Flow %
-0.46%
Top 10 Hldgs %
24.18%
Holding
1,443
New
92
Increased
575
Reduced
559
Closed
58

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$49.3M
2
IQV icon
IQVIA
IQV
+$42.7M
3
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$34.7M
4
COR icon
Cencora
COR
+$32.7M
5
VOO icon
Vanguard S&P 500 ETF
VOO
+$22.7M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$61.8M
2
PGR icon
Progressive
PGR
+$60.9M
3
ANET icon
Arista Networks
ANET
+$23.1M
4
PATH icon
UiPath
PATH
+$22.5M
5
EBAY icon
eBay
EBAY
+$22.2M

Sector Composition

Rank Sector Weight
1 Technology 23.2%
2 Healthcare 11.29%
3 Financials 10.11%
4 Consumer Discretionary 8.76%
5 Industrials 6.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SBAC icon
1051
SBA Communications
SBAC
$18.8B
$347K ﹤0.01%
1,442
-137
-9% -$30.4K
RBA icon
1052
RB Global
RBA
$21.5B
$345K ﹤0.01%
4,292
+1,178
+38% +$95.6K
JLL icon
1053
Jones Lang LaSalle
JLL
$16.1B
$345K ﹤0.01%
+1,280
New +$310K
HRL icon
1054
Hormel Foods
HRL
$14.3B
$341K ﹤0.01%
10,752
-283
-3% -$8.99K
ITB icon
1055
iShares US Home Construction ETF
ITB
$2.34B
$340K ﹤0.01%
2,675
+775
+41% +$89.8K
ACHC icon
1056
Acadia Healthcare
ACHC
$2.59B
$338K ﹤0.01%
5,327
+1,528
+40% +$110K
LW icon
1057
Lamb Weston
LW
$7.49B
$337K ﹤0.01%
5,208
-1,049
-17% -$69.3K
GGAL icon
1058
Galicia Financial Group
GGAL
$7.81B
$337K ﹤0.01%
8,001
-714
-8% -$24.9K
HES
1059
DELISTED
Hess
HES
$336K ﹤0.01%
2,474
+680
+38% +$94.6K
NXP icon
1060
Nuveen Select Tax-Free Income Portfolio
NXP
$900M
$335K ﹤0.01%
22,195
– –
PLXS icon
1061
Plexus
PLXS
$6.28B
$335K ﹤0.01%
2,453
+104
+4% +$12.6K
AMLP icon
1062
Alerian MLP ETF
AMLP
$12.9B
$335K ﹤0.01%
+7,100
New +$336K
LOPE icon
1063
Grand Canyon Education
LOPE
$4.15B
$334K ﹤0.01%
+2,356
New +$340K
LSTR icon
1064
Landstar System
LSTR
$6.11B
$333K ﹤0.01%
1,764
+20
+1% +$3.69K
TYL icon
1065
Tyler Technologies
TYL
$14.2B
$332K ﹤0.01%
569
-57
-9% -$32.1K
CYTK icon
1066
Cytokinetics
CYTK
$10.7B
$331K ﹤0.01%
6,261
-2,761
-31% -$154K
WDS icon
1067
Woodside Energy
WDS
$44B
$328K ﹤0.01%
19,052
+4,000
+27% +$71K
HEFA icon
1068
iShares Currency Hedged MSCI EAFE ETF
HEFA
$7.47B
$328K ﹤0.01%
9,268
– –
NOG icon
1069
Northern Oil and Gas
NOG
$2.26B
$328K ﹤0.01%
9,256
+2,541
+38% +$96.9K
IX icon
1070
ORIX
IX
$42.9B
$325K ﹤0.01%
14,020
+825
+6% +$19.4K
ACMR icon
1071
ACM Research
ACMR
$4.47B
$322K ﹤0.01%
15,867
+107
+0.7% +$2.05K
SEE
1072
DELISTED
Sealed Air
SEE
$321K ﹤0.01%
+8,831
New +$308K
WVE icon
1073
Wave Life Sciences
WVE
$1.1B
$320K ﹤0.01%
39,075
+16,235
+71% +$97K
AFG icon
1074
American Financial Group
AFG
$12.1B
$320K ﹤0.01%
2,374
+8
+0.3% +$1.04K
ALB icon
1075
Albemarle
ALB
$13.4B
$319K ﹤0.01%
3,371
+1,252
+59% +$111K
41 42
43
44 45

Similar funds

EWA
EP Wealth Advisors Torrance, California $20.3B AUM
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
CI Investments Inc
CI Investments Inc Toronto, Ontario, Canada $20.6B AUM 29.22% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
SC
Savant Capital Rockford, Illinois $20.7B AUM 19.76% 1-Year Est. Return

Glenmede Trust's Q3 2024 Portfolio in Review

As of Q3 2024, Glenmede Trust held 1,443 positions worth $20.9B, up 6% from $19.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Glenmede Trust's Q3 2024 filing shows 92 new, 575 increased, 559 reduced and 58 closed positions. Its largest new stake was NOV: 859,708 shares worth $13.7M. The largest sale was Vertex Pharmaceuticals, an estimated $61.8M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • Glenmede Trust's largest Q3 2024 buy was NOV: 859,708 shares worth $13.7M.
  • Glenmede Trust added most to Merck in Q3 2024, an estimated $49.3M increase.
  • Glenmede Trust's biggest Q3 2024 reduction was Vertex Pharmaceuticals, cutting an estimated $61.8M.
  • Glenmede Trust fully exited Pacira BioSciences in Q3 2024, selling an estimated $10.5M.
  • Glenmede Trust's ten largest holdings make up 24% of its $20.9B portfolio in Q3 2024.
  • Glenmede Trust opened 92 new positions and closed 58 in Q3 2024.
  • Glenmede Trust's portfolio value rose 6% quarter-over-quarter to $20.9B.

Based on Glenmede Trust's 13F filing for Q3 2024, filed 13 Nov 2024.